Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

INTRODUCTION: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA), and is being investigated for the treatment of psoriasis. Both conditions can present in women of child-bearing potential, but pregnancy was an exclusion and discontinuation criterion in tofac...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Drug Saf
Main Authors: Clowse, Megan E. B., Feldman, Steven R., Isaacs, John D., Kimball, Alexandra B., Strand, Vibeke, Warren, Richard B., Xibillé, Daniel, Chen, Yan, Frazier, Donald, Geier, Jamie, Proulx, James, Marren, Amy
Format: Artigo
Sprog:Inglês
Udgivet: Springer International Publishing 2016
Fag:
Original Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933738/
https://ncbi.nlm.nih.gov/pubmed/27282428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-016-0431-z
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker